1,262.00
-10(-0.79%)
Currency In JPY
Sector
Healthcare
Industry
Medical - Distribution
Employees
3705
First IPO Date
January 01, 2001
| Name | Title | Pay | Year Born |
| Mr. Taisuke Murai | Chief Executive Officer, C.I.O., President & Representative Director | 0 | 1954 |
| Akira Teramura | Executive Officer and GM of Sales & Purchase Division | 0 | N/A |
| Kenta Sato | Executive Officer & GM of Corporate Communications | 0 | N/A |
| Hideo Takeda | Executive Officer and GM of Legal & Compliance Department | 0 | N/A |
| Mr. Takeshi Ichijo | Executive Vice President & Representative Director | 0 | 1959 |
| Shigemi Naito | Executive Officer & GM of General Affairs & Human Resources Department | 0 | N/A |
| Mr. Kiharu Takahashi | Executive Officer & GM of Corporate Planning Department | 0 | N/A |
| Mr. Soichiro Okamoto | Executive Vice President & Representative Director | 0 | 1963 |
| Hiroshi Yokoyama | Executive Officer and GM of Corporate Planning & Communications Department | 0 | N/A |
| Hiroshi Hiratani | Executive Officer & In Charge of SCM & GM of GDP Management Dept. | 0 | N/A |
Vital KSK Holdings, Inc. engages in the wholesale of pharmaceutical products in Japan. The company is involved in the wholesale of veterinary drugs; agricultural chemicals, agricultural materials, etc.; and medical and nursing care equipment. It also engages in the pharmacy and nursing care businesses; transportation business; insurance agent and real estate management businesses; parking business; mail-order business of health-related products; and pharmacy dispensing business. In addition, the company offers medical management consulting services; and manufactures OTC drugs. The company was founded in 2009 and is headquartered in Tokyo, Japan.